Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,845,663
-$479,545 QoQ
Shares Held
30,439
-1.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#647
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. GILD ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,845,663 | 30,439 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,325,208 | 31,034 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,305,719 | 35,080 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,207,788 | 37,908 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $4,350,206 | 39,237 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $4,384,292 | 39,128 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,774,977 | 40,868 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,434,254 | 40,962 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,980,761 | 43,445 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,702,119 | 36,889 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,835,106 | 34,997 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,405,499 | 32,099 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,400,499 | 31,147 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,782,896 | 33,541 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $6,136,901 | 71,484 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,197,582 | 35,623 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,080,400 | 33,658 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,059,883 | 34,649 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,261,728 | 31,149 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,134,616 | 30,560 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,116,687 | 30,739 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,966,238 | 30,423 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,392,122 | 23,895 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,147,846 | 18,165 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,209,035 | 15,714 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,076,917 | 14,405 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||